Cadence shares soar on patent win
Shares of Cadence Pharmaceuticals jumped 34 percent Friday after the company won a major patent case against a rival drug company, N.C.-based Exela Pharma Sciences. San Diego-based Cadence shares closed at $7.88, up $2 for the day. Cadence said Thursday …